SLC7A5 and prostate carcinoma: It has been suggested that LAT-1 may participate in metastasis and several studies have unveiled a correlation of increased LAT-1 expression with metastasis and worse prognosis in bile duct adenocarcinomas, clear renal cell carcinoma, prostate cancer, and gastric cancer [37,38,39,40].